Washington, June 9 (ANI): In what may become a new drug target for metastatic brain cancer
, scientists from The Scripps Research Institute have discovered a molecular mechanism that plays a pivotal role in controlling cancer growth in the brain.
Fancifully named after the Lone Star State, a light-sensitive drug called texaphyrin has shown success in treating metastatic brain cancer
. Given intravenously to a patient, texaphyrin boosts the effectiveness of X-ray therapy and makes small clusters of cancer cells easier to see on magnetic resonance images.